China approves Oligomannate for the treatment of Alzheimer’s disease
“Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease”.
Latest
Paul Hudson gives hints on a new strategy for Sanofi
Paul Hudson, Sanofi’s newly installed CEO, gave hints on the company new strategy which will be announced at a special event in December 2019.. Hudson joined Sanofi in September and spent the last month on a “listening tour”, spending hours in conference rooms digging into the company portfolio, listening
Neuroscience: the poor cousin of drug discovery
This article was published in a slightly revised form in the February 2019 issue of MedNous
Aging populations everywhere are on the rise creating a need for new medicines to treat neurological disorders. However recent data from the US Food and Drug Administration suggests that this need is not being
Prediction for the Global Pharmaceutical Market
Author: Jean-Claude Muller, 穆卓
Executive Editor at BtoBioInnovation
jcm9144@gmail.com
SPECIAL REPORT #6
A new report issued by IQVIA Institute‘s2018 Global Use of Medicines : 10 Healthcare Predictions for 2019 showed that global spending on medicines reached $1.2 trillion in 2018, up from $1.1 trillion in 2017